Gilead Sciences · 1 day ago
Intern - Finance - MBA Leadership Development Program
San Francisco Bay Area
Internship
Onsite
Intern
$19/hr - $55/hrGilead Sciences is dedicated to creating a healthier world through innovative therapies for major health challenges. The intern will contribute to meaningful projects across various financial domains, gaining valuable experience while supporting the company's mission and initiatives.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
No H1B
Responsibilities
Conduct advanced analyses and make recommendations on reporting, strategy, pricing, and forecasts
Support annual planning, budgeting, and forecasting processes
Deliver accurate and timely management reporting
Build relationships with procurement and operational teams to execute sourcing and procurement programs
Identify and implement process and technology improvements
Support programs that foster a diverse and inclusive culture
Provide financial analysis for cost-reduction initiatives
Create dashboards to identify cost drivers and leverage process improvement methodologies
Manage business-focused projects, including dashboards and reports on progress, risks, and achievements
Organize projects with clear scopes, schedules, and cost estimates
Participate in audits and special projects, learning methodologies and assisting with controls testing
Shape investor communications and manage earnings call processes
Support capital initiatives and meetings with investors and ratings agencies
Identify opportunities and solve business objectives using modern tools
Build analytical models and participate in requirements discussions
Support acquisitions, partnerships, and investments
Execute investment and licensing projects, coordinate diligence, and create business case presentations
Structure and negotiate deal terms
Develop understanding of business and transaction flows
Support efficient and defensible tax structures and respond to evolving tax landscapes
Monitor and analyze balance sheet, cash flow, and risk-based capital
Provide assessments and recommendations on financial trends and acquisitions
Conduct benchmarking and prepare financial reports for internal and external purposes
Gain insight into the pharmaceutical/biotech industry
Develop planning, organizational, and time management skills
Practice team-based work competencies and effective communication with executives and clients
Showcase your work with a final presentation
Qualification
Required
Must be at least 18 years old
Must have a minimum GPA of 2.8
Authorized to work in the United States without Sponsorship now or in the future or CPT/OPT through your University
Must be currently enrolled as a full-time student in a Bachelor's/Masters/MBA/PhD program at an accredited US based university or college
Must be a Rising Sophomore, Junior, or Senior in undergrad or a Graduate or Doctoral Student
Must be enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship
Must be able to complete a 10-12 consecutive week internship between May and August
Must be able to relocate if necessary and work at the designated site for the duration of the internship
Preferred
Preferred Degree qualification: MBA (first-year students preferred)
4+ years of prior consulting, finance, or corporate experience in biotech/pharma
Excellent verbal, written, and interpersonal skills
Strong project management, forecasting, financial modeling, and negotiation skills
Education or training in biological sciences is a plus
Professional certifications (CPA, CFA, PMP) are a plus
Proficiency with MS Office Suite
Ability to identify issues and seek solutions
Ability to work both independently and collaboratively
Demonstrated commitment to inclusion and diversity in the workplace
Efficient, organized, and able to handle short timelines in a fast-paced environment
Benefits
Paid company holidays
Sick time
Housing stipends for eligible employees
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Founded in 1987
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Keeley Wettan
Senior Vice President, Legal
Patrick Loerch
Senior Vice President, Clinical Data Science
Recent News
2025-12-30
BioWorld Financial Watch
2025-12-29
Company data provided by crunchbase